copovithane: structure given in first source
ID Source | ID |
---|---|
PubMed CID | 71487 |
MeSH ID | M0115059 |
Synonym |
---|
bay-i-7433 |
copovithane |
copovithane [ban] |
68045-74-9 |
unii-3hbm8v07b2 |
bay i 7433 |
3hbm8v07b2 , |
1-ethenylpyrrolidin-2-one;2-(methylcarbamoyloxymethyl)prop-2-enyl n-methylcarbamate |
Excerpt | Reference |
---|---|
"Bay i 7433 (Copovithane) is a biological response modifier with antitumour activity in vivo, but no cytotoxic or cytostatic effect in vitro. " | ( Danova, M; Faravelli, M; Girino, M; Riccardi, A; Salvini, P; Ucci, G, 1986) |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 8 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 2 (25.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (75.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Article | Year |
---|---|
Pharmacokinetics and tissue disposition of the biological response modifier BAY i 7433 (copovithane) in patients with cancer. Cancer chemotherapy and pharmacology, Volume: 18, Issue: 3 | 1986 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Article | Year |
---|---|
Reversal of cyclosporine-induced mortality with a synthetic polymeric immunostimulant in a murine model of fecal peritonitis. Transplantation, Volume: 39, Issue: 4 | 1985 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |